Načítá se...
Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period
AIM: To investigate seven CA125 criteria to monitor progressive ovarian cancer among patients with stage IC–IV disease. MATERIALS & METHODS: Four criteria were used to asses CA125 increments starting from concentrations ≥35 U/ml and three criteria to asses increments starting from concentrations...
Uloženo v:
| Vydáno v: | Future Sci OA |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Science Ltd
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5583662/ https://ncbi.nlm.nih.gov/pubmed/28884012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fsoa-2017-0023 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|